What is the best strategy for improving male fertility with GLP-1s
Specifically, the FDA is requiring Lilly to complete various post-marketing clinical trials of Foundayo to look at the potential risks for various side effects, including cardiovascular events, liver toxicity, and delayed gastric emptying (gastroparesis), as non-clinical or observational studies will not be sufficient
Semaglutide's journey from diabetes medication to weight loss therapy spans over a decade of clinical research and real-world application
According to one survey, a net 30% of people who quit a GLP-1 medication actually eat more calories than they did before they began the course, leading to what has been termed the Ozempic rebound
Many of our patients experience changes in markers related to liver health, blood sugar, and hormones